Skip to main content

Table 3 Medications used to treat terminal pancreatic patients according to end-of-life care

From: How different is the care of terminal pancreatic cancer patients in inpatient palliative care units and acute hospital wards? A nationwide population-based study

Ranking Inpatient palliative care (n = 276) Acute hospital care (n = 276)
Drug class (ATC code) n % Drug class (ATC code) n %
1 Natural opium alkaloids (N02AA) 233 84.4 Solutions affecting the electrolyte balance (B05BB) 268 97.1
2 Solutions affecting the electrolyte balance (B05BB) 221 80.1 Solutions for parenteral nutrition (B05BA) 223 80.8
3 Propulsives (A03FA) 152 55.1 Propulsives (A03FA) 200 72.5
4 Contact laxatives (A06AB) 146 52.9 Plain sulfonamide diuretics (C03CA) 198 71.7
5 Benzodiazepine derivatives (N05CD) 133 48.2 Electrolyte solutions (B05XA) 184 66.7
6 Solutions for parenteral nutrition (B05BA) 124 44.9 Contact laxatives (A06AB) 167 60.5
7 Glucocorticoids (H02AB) 123 44.6 Cephalosporins (J01DA) 167 60.5
8 Plain sulfonamide diuretics (C03CA) 118 42.8 Phenylpiperidine derivatives opioids (N02AB) 159 57.6
9 Butyrophenone derivatives antipsychotics (N05AD) 111 40.2 Natural opium alkaloids (N02AA) 156 56.5
10 Magnesium compounds (A02AA) 108 39.1 Adrenergic and dopaminergic agents (C01CA) 146 52.9
  1. ATC Anatomical Therapeutic Chemical